Lieberman, R <br/><br/>
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.  [electronic resource] 

 -  Urology  Apr 2001 
 - 4-27 p.  digital 
<br/><br/> Publication Type: Congress 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/s0090-4295(00)00931-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticarcinogenic Agents--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor<br/>Clinical Trials as Topic<br/>Drug Industry<br/>Government<br/>Humans<br/>Interinstitutional Relations<br/>Male<br/>Middle Aged<br/>National Institutes of Health (U.S.)<br/>Practice Guidelines as Topic<br/>Prostatic Neoplasms--prevention & control<br/>United States<br/>United States Food and Drug Administration